The rise of AI is revolutionizing medical technology, but it presents a unique challenge for regulators. How does the FDA approve a device that is designed to change and learn over time? This episode of MedTech Global Insights dives deep into the FDA's framework for AI-powered medical software, offering a clear guide for innovators.We break down the essentials of the premarket submission process, moving beyond traditional models. We explore the critical concept of the Predetermined Change Control

️ Episode 179: Mosaicism for Autosomal Trisomies: Maternal Age, UPD, and Reproductive History in 1,266 Cases In this episode of PaperCast Base by Base, we explore a comprehensive literature analysis of 1,266 reported cases of autosomal trisomy mosaicism, contrasting prenatal cohorts—true fetal mosaicism and confined placental mosaicism—with postnatal diagnoses to clarify how maternal age and reproductive history relate to outcomes and uniparental disomy.

️ Episode 179: Mosaicism for Autosomal Trisomies: Maternal Age, UPD, and Reproductive History in 1,266 Cases In this episode of PaperCast Base by Base, we explore a comprehensive literature analysis of 1,266 reported cases of autosomal trisomy mosaicism, contrasting prenatal cohorts—true fetal mosaicism and confined placental mosaicism—with postnatal diagnoses to clarify how maternal age and reproductive history relate to outcomes and uniparental disomy.

Scientist throw around words and phrases that are sometimes hard to understand. This is not one of them. Genetic drift is an easy concept. Dr Rob brings up the example drift among of human mitochondria, perhaps the most extreme form anyone has ever seen. And, since natural selection is generally weak, genetic drift overwhelms selection at critical junctures during development. This has profound implications for the creation-evolution debate, but first, the explanation...Source paper under

Puerto Rico is entering a new era in microbiome research. In this episode,  Luis speaks with Dr. Filipa Godoy-Vitorino about the newly established Microbiome Center of Puerto Rico — a hub designed to strengthen research, collaboration, and training across the Caribbean. Dr. Godoy-Vitorino shares how the center is helping scientists access expertise in bioinformatics and data analysis, offering bilingual workshops, and expanding representation of Caribbean populations in global microbiome studies

Dr. Amelia Scott Barrett, MD, and Dr. Elizabeth Yarnell, ND, delve into the connections between diet, migraines, and multiple sclerosis. Dr. Yarnell shares her expertise on managing migraines through dietary adjustments and food sensitivity testing. They discuss the impact of chronic inflammation, the mediator release test (MRT), and personalized health plans using genetic testing. Key dietary elements, including high fructose corn syrup, food additives, and alternative sweeteners, are examined for

In this episode of Protein Production Technology International, Hermes Sanctorum, co-founder and CEO of Paleo, and Pierre Donck, Chief Business Officer, discuss how precision fermentation is shaping the future of plant-based foods. They share the company’s mission-driven journey, rooted in sustainability and animal welfare, and explain how hem proteins can transform the taste, color, and authenticity of alternative meats. Hermes reflects on his transition from policymaking to

Predicting, not just explaining, can change how we design GPCR-targeted drugs. Jens Carlsson reveals how modeling bridges structure, function, and pharmacology.Hear how predictive simulations shape assay development, GPCR drug discovery, and collaborations across disciplines.🎓 Join Dr. GPCR Premium for exclusive episodes + research tools → https://www.ecosystem.drgpcr.com/gpcr-university-pricing Watch the complete episode at

In this episode, Darshan Kulkarni speaks with Dae Lee about the growing conflict between pharmaceutical manufacturers and pharmacy benefit managers (PBMs) — and how it’s reshaping the U.S. drug supply chain. They unpack the recent dispute involving AstraZeneca, which alleges discrepancies between the number of branded claims submitted by pharmacies through PBMs and the rebates invoiced by those PBMs. The issue shines a spotlight on how PBMs control formulary access and drug distribution, ofte...

This cross-platform podcast is shared on Science Facts and Fallacies as well as Talking Biotech.  Cameron English, Dr. Liza Lockwood and Dr. Kevin Folta discuss the comments made during a rant on the Science Facts and Fallacies podcast concerning the rigor of peer review and alledged lack of self policing in academic publishing.  They discuss several papers in the recent public eye, with an emphasis on the process, the media response, and the nuance that is used in academic publishing,

Dr. Alex Crespo speaks with Colonel Dan Stinner, MD about his experience as a US Army surgeon and how young surgeons can pursue military service. For additional educational resources visit OTA.org

Today’s episode with an openminded global citizen that dares to wear a Birkin bag. Meet Niklas: A designer at heart, inspired by movement, people, and everyday moments. Balancing creativity, discipline, and the curiosity for what comes next.@drschwank @unesurecent @maisonbyniklas

In this episode of Denatured, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney will explore how healthcare and pharmaceutical players — from hospitals and universities to manufacturers and investors — are rethinking their strategies amid global supply chain disruption.The conversation highlights both immediate operational responses and long-term structural shifts shaping a more resilient, agile, and locally grounded ecosystem, especially in light of U.S. tariffs.This episode is presented in

On September 30, Medical Alley hosted Women in Health Leadership, bringing together an extraordinary group of leaders for connection, reflection, and growth. The featured speaker was Sheri Dodd, CEO of Tactile Medical. Sheri is a seasoned executive with vast experience in the pharmaceutical, medical device, and digital health sectors. She is widely respected for her insight, integrity, and perspectives on healthcare transformation and leadership and offered lessons in leadership and ins...

About this podcast:This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. For more information, go to IO360summit.com.

Have you ever wondered if manual therapy is useful in the later stages of rehab?  In this episode< Dr. Zach Baker and Dr. Corrie Jones talk about times and situations where manual therapy really can be helpful during those bridge phases in leaning towards performance and return to sport.  There are definitely appropriate times and places where this can be something the keeps your athletes on-track and helps ensure progression through the phases.  Listen in to hear what years of experience and

About this podcast:This podcast comes from the 2025 Patients as Partners in Clinical Research conference. This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participationSuccessful models for empowering local leaders and leveraging

“We have strong scientific foundations and manufacturing excellence. Now we’re creating the ecosystem to help biotechs scale and compete globally,” says Federico Vigano, Board Member of Assobiotec.Federico Vigano, Country Manager for Vertex in Italy and Greece, brings extensive pharmaceutical leadership experience from roles at AstraZeneca, Boehringer Ingelheim and GSK. As a board member of Assobiotec, the Italian Association for the Development of Biotechnology representing over 100 companies and